Amundi Standard Biotools Inc. Transaction History
Amundi
- $253 Billion
- Q2 2024
A detailed history of Amundi transactions in Standard Biotools Inc. stock. As of the latest transaction made, Amundi holds 14,497 shares of LAB stock, worth $25,369. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,497Holding current value
$25,369% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
149Shares Held
269MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$112 Million9.76% of portfolio
-
Viking Global Investors LP58.7MShares$103 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$38.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$28 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$22.6 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $138M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...